SenzaGen’s tests identify potentially harmful chemicals. It is more relevant and cost-efficient, making animal testing unnecessary and daily products safer.

GLP Compliant Laboratory

Skin sensitization

GARD®skin and GARD®skin Medical Device are robust in vitro assays to identify potential chemical skin sensitizers with over 90% prediction accuracy.

Skin potency classification

GARD®potency is an add-on in vitro test to GARDskin for potency classification according to GHS/CLP (1A or 1B).

Respiratory sensitization

GARD®air is the first in vitro assay capable of identifying chemical respiratory sensitizers. It can be used alone or in combination with GARDskin to discriminate between respiratory and skin sensitizers.

Press Releases

16 Sep, 2020
Corporate Information
Order
English
News
IR
Sales
11 Sep, 2020
IR
English
Sales
News
Order
Corporate Information
20 Aug, 2020
Interim
Regulatory
English
MAR
Report
IR
News
Q2

Subscribe


Prenumerera